KTX-951
Product Specifications
CAS Number
2573298-36-7
Target
IRAK, PROTACs
Related Pathways
Immunology/Inflammation, NF-κB, PROTAC
Bioactivity
KTX-951, a PROTAC designed for IRAK4 degradation (DC 50 =18 nM), exhibits an oral bioavailability (F%) of 22% in a rat model at a dosage of 10 mg/kg. Additionally, KTX-951 demonstrates promising anticancer potential [1].
Smiles
COc1cc2nn(cc2cc1NC(=O)c1cccc(n1)C(C)(F)F)[C@H]1CC[C@H](CN2CCC3(CC(CCNc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)C3)CC2)CC1
Molecular Formula
C46H52F2N8O6
Molecular Weight
850.95
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
465337-01 10 mg
S-2-Amino-N- (S-1- (4-hydroxyphenyl) -3-oxopropan-2-yl) -3-methylbutanamide
Sign In for Pricing
View Details 465337-02 25 mg
S-2-Amino-N- (S-1- (4-hydroxyphenyl) -3-oxopropan-2-yl) -3-methylbutanamide
Sign In for Pricing
View Details 
437716-01 100 mg
6- (gamma, gamma-Dimethylallylamino) purine Riboside Hemihydrate
Sign In for Pricing
View Details 437716-02 250 mg
6- (gamma, gamma-Dimethylallylamino) purine Riboside Hemihydrate
Sign In for Pricing
View Details LV758139 1.0 µg DNA
BVES-AS1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details